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impact of mismatches on the recombina-
tion efficiency. Their reporter was inte-
grated in the genome in such a way that
they coulduseoneCrispr/Cas9guideRNA
to cut near the upstream homology region
and a second guide RNA to cut varying
distances (16 bp to 28.4 kb) from the
downstream homology region.
Using their assay [7], the Stark lab showed
that the frequency of repeat-mediated
deletions (RMDs) increased when the
DSB is close to the repetitive elements
and declines rapidly with distance, fol-
lowed by a very gradual decline up to at
least 28.4 kb. At the longer distances, the
RMD was much more dependent on
Rad52 then at shorter distances. The role
of Rad52 in SSA is to help anneal homolo-
gous or homologous sequences to form
heteroduplexes [1],whereasNHEJandalt-
NHEJ pathways are Rad52-independent.
They also showed that even amodest level
of mismatch between the repetitive
sequences (1–3%) significantly inhibited
RMD at all distances. This inhibition by
mismatches between repetitive elements
was largely dependent on Msh2, which
would be expected for a processmediated
by heteroduplex rejection [9].
This new study tested the dependence of
RMD on various proteins involved in DSB
repair. For example, loss of KU70 and
XRCC4 (proteins involved in c-NHEJ)
increased RMD, while loss of CtIP and
BRCA1 (which are involved in the resec-
tion pathway) was found to decrease
RMD. This indicates that there may be
competition between the nonresection
and resection pathways (Figure 1). How-
ever, the authors found that direct regu-
lation by heteroduplex rejection (Msh2-
mediated) is a stronger inhibitor of RMD
than competition with c-NHEJ. These
data indicate that there could be multiple
pathways that suppress RMD between
the high concentration of repetitive
sequences throughout the genome.
The presence of dispersed Alu elements
throughout the genome [3], and other
repetitive DNA sequences, provides end-
less opportunities for RMDs that disrupt
genome function. The relatively efficient
excision of tens of kilobases of DNA at
DSBs means that many copies of Alu
may be exposed in single-strand regions,
leading to many possible rearrangements.
The human genome could not survive the
resulting instability if it did not have strong
regulators inhibiting these RMDs.
There are a number of situations in which
someof theDSBrepairpathwaysareeither
suppressed or defective in humans. Can-
cer is the most obvious situation in which
some of these genes, such as msh2,
brca1, and brca2 are commonly defective.
Thus, in various cancers onemight expect
tosee increases in theabundanceofRMDs
andpossibly other changes in thenature of
repeat-mediated genomic rearrange-
ments that might lead to more genetic
instability, which in turn helps the cancer
evolve to a more malignant form.
1Tulane Cancer Center, Tulane University, New Orleans,
LA 70122, USA
*Correspondence: pdeinin@tulane.edu (P. Deininger).
https://doi.org/10.1016/j.tig.2018.05.003
References
1. Ceccaldi, R. et al. (2016) Repair pathway choices and conse-
quencesat thedouble-strandbreak.TrendsCellBiol.26,52–64
2. Symington, L.S. and Gautier, J. (2011) Double-strand break
end resection and repair pathway choice.Annu. Rev. Genet.
45, 247–271
3. Lander, E.S. et al. (2018) Initial sequencing and analysis of
the human genome. Nature 409, 860–921
4. Carvalho, C.M. and Lupski, J.R. (2016) Mechanisms under-
lying structural variant formation in genomic disorders. Nat.
Rev. Genet. 17, 224–238
5. Belancio, V.P. et al. (2008) Mammalian non-LTR retrotrans-
posons: for better or worse, in sickness and in health.
Genome Res. 18, 343–358
6. Morales, M.E. et al. (2015) The contribution of alu elements
to mutagenic DNA double-strand break repair. PLoS Genet.
11, e1005016
7. Mendez-Dorantes, C. et al. (2018) Repeat-
mediated deletions can be induced by a
chromosomal break far from a repeat, but multiple
pathways suppress such rearrangements. Genes Dev.
32, 524–536
8. Gunn, A. and Stark, J.M. (2012) I-SceI-based assays to
examine distinct repair outcomes of mammalian
chromosomal double strand breaks. Methods Mol. Biol.
920, 379–391
9. Sugawara, N. et al. (2004) Heteroduplex rejection during
single-strand annealing requires Sgs1 helicase and mis-
match repair proteins Msh2 and Msh6 but not Pms1. Proc.
Natl. Acad. Sci. U. S. A. 101, 9315–9320
Forum
Rad5, HLTF, and
SHPRH: A Fresh View
of an Old Story
Menattallah Elserafy,1,2,3
Arwa A. Abugable,2,3
Reham Atteya,2 and
Sherif F. El-Khamisy1,2,*,@
Not only have helicase-like tran-
scription factor (HLTF) and SNF2
histone-linker PHD-finger RING-fin-
ger helicase (SHPRH) proved to be
importantplayers inpost-replication
repair like their yeast counterpart,
Rad5, but they are also involved in
multiple biological functions andare
associated with several human dis-
orders.We provide here an updated
view of their functions, associated
diseases, and potential therapeutic
approaches.
RAD5, a Gene [134_TD$DIFF]All Budding Yeast
Laboratories Should Know about
Yeast has served as a prominent model
organism in DNA repair research for dec-
ades [1]. Rad5 is a RING-finger-containing
ubiquitin ligase and helicase [135_TD$DIFF]that was
discovered in budding yeast and was
found to play a role in template switching
(TS) and translesion synthesis (TLS) post-
replication repair (PRR) mechanisms. TS
utilizesaclevermechanismusing thenewly
synthesized sister DNA strand as a tem-
plate tobypass lesions,whileTLSswitches
replicative polymerases to low-fidelity pol-
ymerases to overcome lesions [2].
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The wild-type W303 yeast strain used by
numerous laboratories harbors a RAD5
mutation (rad5-535). Some researchers
have started to use a strain in which the
mutation has been corrected. Conse-
quently, conflicting results have been
reported in the literature by laboratories
using the W303 rad5-535 versus W303
RAD5 strains [3]. While it is important to
raise the awareness of yeast researchers
to the importance of RAD5 genotype in
yeast, it is equally important to highlight
how the mammalian Rad5 orthologs,
such as HLTF and SHPRH, play multiple
important roles in mammalian cells.
HLTF and SHPRH; Rad5 Human
Orthologs
HLTF is considered to be the closest
ortholog to yeast Rad5; it shows higher
sequence conservation to Rad5 than to
SHPRH. HLTF contains the conserved
HIRAN domain that is responsible for
30-single-stranded (ss)DNA binding [4],
and is able to complement UV sensitivity
in the Drad5 yeast strain. It also pos-
sesses double-stranded (ds)DNA translo-
case activity which is utilized to reverse
stalled replication forks [5]. Similarly to
yeast Rad5, both HLTF and SHPRH are
E3 ubiquitin ligases and have been shown
to polyubiquitinate PCNA, in cooperation
with Ubc13–MMS2, in response to DNA
damage, thereby directing PRR towards
the TS repair pathway [6,7]. The homol-
ogy between Rad5, HLTF, and SHPRH is
depicted in Figure 1A [2].
HLTF and SHPRH in Disease
Cancer
A large body of evidence indicates that
HLTF is a tumor-suppressor gene [2].
Methylation and silencing of HLTF have
been documented in several cancers
such as colon, gastric, esophageal, uter-
ine, lung, hepatocellular, and bladder
cancer [2,8].HLTF promoter hypermethy-
lation in the blood of cancer patients has
been investigated as a tumor biomarker
to predict prognosis and survival. More-
over, in cervical, thyroid, and head and
neck cancers, alternative splicing of HLTF
mRNA increases the expression of trun-
cated versions lacking functional DNA
repair domains [8]. Heterozygosity in the
long arm of chromosome 6, where the
SHPRH gene resides, has been reported
in malignant melanoma, ovarian, and cer-
vical cancers. Furthermore, SHPRH was
found to be truncated or to contain mis-
sense mutations in tumor cell lines, which
is consistent with a tumor-suppressor
function [2].
Interestingly,HLTFwas found to be one of
the genetic determinants conferring sensi-
tivity or resistance to lysosomal autophagy
inhibitors such as hydroxychloroquine
(HCQ) in several cancer cell lines [8]. HLTF
expression was found to be low in HCQ-
sensitive cell lines and high in resistant cell
lines. HLTF protected against HCQ-
induced cell death because it is essential
for repairing the resulting reactive oxygen
species (ROS)-induced DNA damage [8].
Because lysosome inhibitors are currently
in clinical trials for efficacyas single or com-
bined anticancer agents, HLTF expression
profilingof patientsmaybehelpful todeter-
mine the response [8] (Figure 1B). We sug-
gest designing HLTF inhibitors for
anticancer therapy because combining
themwithautophagy inhibitorscouldprove
to be synergistic. Moreover, one could
question whether cancerswith downregu-
lated SHPRH expression would also
respond to autophagy inhibitors. Similarly,
it is tempting to test whether inhibiting
SHPRHwould also synergizewith autoph-
agy inhibitors (Figure 1B).
HLTF and HIV-1
Upon HIV-1 infection of target cells, viral
protein R (Vpr) downregulates HLTF [9].
Vpr is known to recruit CRL4 (DCAF1) E3
ligase to mediate HLTF degradation, and
thus facilitates viral replication. A highly
conserved zinc-binding motif (HHCH) in
Vpr is required for the interaction between
Vpr and DCAF1 [9]. Mutations in this motif
or the addition of a zinc-chelating agent,
TPEN [136_TD$DIFF]N,N,N,N-tetrakis-(2-pyridylmethyl)
ethylenediamine, was found to disrupt
the Vpr–CRL4 (DCAF1) interaction and
therefore their function. Nevertheless,
TPEN did not affect the assembly of the
cellular CRL4 E3 complex. This opens the
door to developing novel antiviral thera-
pies [137_TD$DIFF]against HIV-1 in which the interaction
between Vpr and CRL4/DCAF1 is selec-
tively disrupted [9] (Figure 1B).
HLTF and Inflammatory Bowel Disease
(IBD)
Gene expression analysis of regenerating
gene (REG) familymembers has shown that
thegenesencodingREG-Ia (REG1A),REG-
Ib (REG1B), and REG-IV (REG4) are over-
expressed in IBD. Upregulation of REG
genes isbeneficialon theonehandbecause
it induces the proliferation of intestinal epi-
thelial cells, protecting them from damage
caused by the immune system, but on the
otherhandupregulation increases theriskof
developing colon cancer [10].
A recent study investigating the link
between REG genes and IBD reported
that REG1A, REG1B, and REG4 are over-
expressed in the colon of Crohn’s disease
patients, and that REG4 is overexpressed
in the colon of ulcerative colitis patients
[10]. IL-22 was found to induce REG1B
overexpression through activating the
REG1B promoter region which contains
a binding site for HLTF. Knockdown of
HLTF was found to decrease the expres-
sion of IL-22-induced REG Ib [10]. To
prevent the development of colon cancer
after intestinal epithelium recovery, the
study suggested that anti-IL-22 and
anti-REG proteins could be administered
to patients. We also propose that devel-
oping inhibitors that prevent the interac-
tion between HLTF and the REG1B
promoter could be useful to reduce the
expression of REG-1b after colon regen-
eration, and thus reduce the risk of colon
cancer (Figure 1B).
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Figure 1. A Fresh View of HLTF and SHPRH. (A) Homology between Rad5, HLTF, and SHPRH. Similarly to Rad5, HLTF contains the conservedHIRANdomain. All
three proteins contain the RING finger domain embedded between the SNF2 helicase motifs. SHPRH also contains a H15 linker histone H1/H5 domain and a PHD-
finger domain. Panel adapted, with permission, from [2]. (B) Biological functions and associated diseases for HLTF and SHPRH, and potential therapeutic approaches.
HLTF plays a role in the regulation of clock-controlled genes in GH4C1 cells, in mouse embryonic and postnatal brain development, and in collagen biogenesis in the
heart. In addition, downregulation or truncation of HLTF and SHPRH have been implicated in different cancers. Cancer cells with low HLTF expression were found to be
sensitive to lysosomal autophagy inhibitors [131_TD$DIFF]. HLTF is also involved in REG1B overexpression, increasing the risk of colon cancer in IBD patients. Zinc-chelating agent
prevents HLTF degradation by HIV-1. We propose testing the effect of the lysosomal autophagy inhibitors on cancers with low SHPRH levels. We also propose
designing HLTF and SHPRH inhibitors to be tested in combination [132_TD$DIFF]with lysosomal autophagy inhibitors. Abbreviations: aa, amino acids; IBD, [133_TD$DIFF]inflammatory bowl disease.
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HLTF in Biological Functions
HLTF in the Regulation of Clock-
Controlled Genes (CCGs)
The majority of CCGs involved in circa-
dian rhythm regulation lack the specific E-
box response element required for regu-
lation. A study was conducted on the
GH4C [138_TD$DIFF] rat pituitary somatolactotroph cell
line to investigate the mechanism of tran-
scription of prolactin (Prl), a CCG that
lacks the specific E-box element. HLTF
was found to interact with PIT-1 transcrip-
tion factor at the P2 region of the Prl
promoter, which is different from the spe-
cific E-box that is usually bound by CCGs.
HLTF and PIT-1 are not rhythmically
expressed; however, HLTF interacts with
NONO and SFPQ proteins which rhyth-
mically bind to the Prl gene. Therefore,
this leads to Prl expression that is neces-
sary for maintaining the normal circadian
pattern. These findings have uncovered a
novel role for HLTF in the regulation of the
oscillatory expression of CCGs that lack
the specific E-box response element [11]
(Figure 1B).
HLTF in Mouse Embryonic and
Postnatal Development
HLTF has been shown to play crucial roles
in embryonic and postnatal development
of the murine heart and brain [12,13]. In
mouse heart, HLTF is necessary for hyp-
oxia-inducible factor1a (HIF-1a) regulation
to achieve normal collagen biogenesis. In
addition, HLTF regulates the expression of
the cohesion and condensin complexes,
as well as of cell-cycle regulators, during
embryonic development of mouse brain.
Therefore,asignificantpercentageofHLTF
null mice die, and those that survive suffer
fromDNAdamage, increased apoptosis in
brain, brain encephalomalacia, G2/M tran-
sitiondefects, and fibrillar networkdisorga-
nization [12,13] (Figure 1B).
Concluding Remarks
There is increasing interestamongscientists
in discovering different roles for the Rad5
human homologs. HLTF is especially inter-
esting because any associated defects
would not only affect the DNA repair activity
in cells but also the expression level of mul-
tiple genes that are potentially implicated in
differentdisorders.Weproposethatdefects
in HLTF and SHPRH could be associated
with multiple disorders that have not yet
been identified. They could also be utilized
as biomarkers and exploited as potential
therapeutic targets. Further work will shed
light on novel approaches to selectively tar-
get the perturbed functions of HLTF and
SHPRH while retaining their important role
in unaffected tissues.
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